Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$110M |
| 2 |
Willis Towers Watson
WTW
|
+$70.4M |
| 3 |
Gen Digital
GEN
|
+$63.3M |
| 4 |
Goldman Sachs
GS
|
+$53.6M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$51.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$110M |
| 2 |
Meta Platforms (Facebook)
META
|
+$72.2M |
| 3 |
Global Payments
GPN
|
+$43.3M |
| 4 |
Cardinal Health
CAH
|
+$41.2M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$40.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.08% |
| 2 | Technology | 14.83% |
| 3 | Healthcare | 8.61% |
| 4 | Consumer Discretionary | 7.67% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
BioMarin Pharmaceuticals
BMRN
$12.6B
| $2.27M | 0.02% |
+29,300
| New | +$2.31M |
|
677
PUT
Edwards Lifesciences
EW
$52.3B
| $2.26M | 0.02% |
+20,000
| New | +$2.28M |
|
678
Iovance Biotherapeutics
IOVA
$3.68B
| $2.26M | 0.02% |
91,641
+82,441
| +896% | +$1.94M |
|
679
Banco Bilbao Vizcaya Argentaria
BBVA
$161B
| $2.25M | 0.02% |
341,232
-44,842
| -12% | -$290K |
|
680
iShares Global Clean Energy ETF
ICLN
$2.18B
| $2.25M | 0.02% |
103,889
+81,889
| +372% | +$1.87M |
|
681
Knight Transportation
KNX
$11.3B
| $2.23M | 0.02% |
+43,546
| New | +$2.19M |
|
|
OPLN
682
Openlane
OPLN
$4.16B
| $2.22M | 0.02% |
+135,637
| New | +$2.29M |
|
683
Yum! Brands
YUM
$42.8B
| $2.2M | 0.02% |
18,000
+7,589
| +73% | +$963K |
|
684
Target
TGT
$76.9B
| $2.2M | 0.02% |
+9,600
| New | +$2.4M |
|
685
Corpay
CPAY
$27.3B
| $2.19M | 0.02% |
8,400
-24,015
| -74% | -$6.21M |
|
686
Match Group
MTCH
$9.55B
| $2.18M | 0.02% |
13,900
-15,993
| -54% | -$2.44M |
|
687
Novartis
NVS
$300B
| $2.16M | 0.02% |
+26,400
| New | +$2.38M |
|
688
POSCO
PKX
$17.7B
| $2.16M | 0.02% |
31,300
+10,400
| +50% | +$766K |
|
689
Array Technologies
ARRY
$701M
| $2.14M | 0.02% |
+115,394
| New | +$1.91M |
|
|
RIDE
690
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $2.14M | 0.02% |
17,840
+13,187
| +283% | +$1.37M |
|
691
Rocket Pharmaceuticals
RCKT
$384M
| $2.13M | 0.02% |
71,270
+35,067
| +97% | +$1.28M |
|
|
COHR
692
DELISTED
Coherent Inc
COHR
| $2.13M | 0.02% |
8,500
-14,254
| -63% | -$3.58M |
|
693
KLA
KLAC
$238B
| $2.11M | 0.02% |
63,100
+51,610
| +449% | +$1.72M |
|
|
PSTX
694
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.11M | 0.02% |
289,179
+34,576
| +14% | +$297K |
|
|
695
Amazon
AMZN
$2.83T
| $2.09M | 0.02% |
12,720
-636,120
| -98% | -$110M |
|
|
LGF.A
696
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $2.09M | 0.02% |
147,200
+122,506
| +496% | +$1.79M |
|
697
Morgan Stanley
MS
$337B
| $2.09M | 0.02% |
21,436
-62,195
| -74% | -$6.16M |
|
698
Zebra Technologies
ZBRA
$17.1B
| $2.08M | 0.02% |
4,041
-13,009
| -76% | -$7.25M |
|
|
BRSL
699
Brightstar Lottery PLC
BRSL
$2.17B
| $2.07M | 0.02% |
78,800
+20,300
| +35% | +$430K |
|
700
Kinross Gold
KGC
$39.2B
| $2.07M | 0.02% |
386,689
+193,041
| +100% | +$1.16M |
|
Similar funds
Steve Schonfeld's Q3 2021 Portfolio in Review
As of Q3 2021, Steve Schonfeld held 2,698 positions worth $9.68B, up 3% from $9.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Steve Schonfeld deployed $368M of net new capital in Q3 2021, opening 807 new positions and adding to 606 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $110M trimmed.
- Steve Schonfeld's largest Q3 2021 buy was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
- Steve Schonfeld added most to Willis Towers Watson in Q3 2021, an estimated $70.4M increase.
- Steve Schonfeld's biggest Q3 2021 reduction was Amazon, cutting an estimated $110M.
- Steve Schonfeld fully exited Cardinal Health in Q3 2021, selling an estimated $41.2M.
- Steve Schonfeld's ten largest holdings make up 11% of its $9.68B portfolio in Q3 2021.
- Steve Schonfeld opened 807 new positions and closed 588 in Q3 2021.
- Steve Schonfeld's portfolio value rose 3% quarter-over-quarter to $9.68B.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.